These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

413 related items for PubMed ID: 9002223

  • 1. Angiostatin: an endogenous inhibitor of angiogenesis and of tumor growth.
    O'Reilly MS.
    EXS; 1997; 79():273-94. PubMed ID: 9002223
    [Abstract] [Full Text] [Related]

  • 2. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma.
    O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, Lane WS, Cao Y, Sage EH, Folkman J.
    Cell; 1994 Oct 21; 79(2):315-28. PubMed ID: 7525077
    [Abstract] [Full Text] [Related]

  • 3. A recombinant human angiostatin protein inhibits experimental primary and metastatic cancer.
    Sim BK, O'Reilly MS, Liang H, Fortier AH, He W, Madsen JW, Lapcevich R, Nacy CA.
    Cancer Res; 1997 Apr 01; 57(7):1329-34. PubMed ID: 9102221
    [Abstract] [Full Text] [Related]

  • 4. Angiostatin suppresses malignant glioma growth in vivo.
    Kirsch M, Strasser J, Allende R, Bello L, Zhang J, Black PM.
    Cancer Res; 1998 Oct 15; 58(20):4654-9. PubMed ID: 9788618
    [Abstract] [Full Text] [Related]

  • 5. Mutation of human plasminogen kringle 1-5 enhances anti-angiogenic action via increased interaction with integrin alpha(v)beta(3).
    Chang PC, Chang YJ, Wu HL, Chang CW, Lin CI, Wang WC, Shi GY.
    Thromb Haemost; 2008 Apr 15; 99(4):729-38. PubMed ID: 18392331
    [Abstract] [Full Text] [Related]

  • 6. A novel strategy for the tumor angiogenesis-targeted gene therapy: generation of angiostatin from endogenous plasminogen by protease gene transfer.
    Matsuda KM, Madoiwa S, Hasumi Y, Kanazawa T, Saga Y, Kume A, Mano H, Ozawa K, Matsuda M.
    Cancer Gene Ther; 2000 Apr 15; 7(4):589-96. PubMed ID: 10811477
    [Abstract] [Full Text] [Related]

  • 7. [Angiostatin. A biological inhibitor of tumor angiogenesis].
    Thimme R, Spangenberg HC, Blum HE.
    Dtsch Med Wochenschr; 1997 Mar 27; 122(13):413-4. PubMed ID: 9138915
    [No Abstract] [Full Text] [Related]

  • 8. Radiation therapy to a primary tumor accelerates metastatic growth in mice.
    Camphausen K, Moses MA, Beecken WD, Khan MK, Folkman J, O'Reilly MS.
    Cancer Res; 2001 Mar 01; 61(5):2207-11. PubMed ID: 11280788
    [Abstract] [Full Text] [Related]

  • 9. Suppression of tumor growth with recombinant murine angiostatin.
    Wu Z, O'Reilly MS, Folkman J, Shing Y.
    Biochem Biophys Res Commun; 1997 Jul 30; 236(3):651-4. PubMed ID: 9245707
    [Abstract] [Full Text] [Related]

  • 10. The tumor-suppressing activity of angiostatin protein resides within kringles 1 to 3.
    MacDonald NJ, Murad AC, Fogler WE, Lu Y, Sim BK.
    Biochem Biophys Res Commun; 1999 Oct 22; 264(2):469-77. PubMed ID: 10529387
    [Abstract] [Full Text] [Related]

  • 11. Selective inhibition by kringle 5 of human plasminogen on endothelial cell migration, an important process in angiogenesis.
    Ji WR, Barrientos LG, Llinás M, Gray H, Villarreal X, DeFord ME, Castellino FJ, Kramer RA, Trail PA.
    Biochem Biophys Res Commun; 1998 Jun 18; 247(2):414-9. PubMed ID: 9642142
    [Abstract] [Full Text] [Related]

  • 12. Angiostatin inhibits pathological but not physiological retinal angiogenesis.
    Drixler TA, Borel Rinkes IH, Ritchie ED, Treffers FW, van Vroonhoven TJ, Gebbink MF, Voest EE.
    Invest Ophthalmol Vis Sci; 2001 Dec 18; 42(13):3325-30. PubMed ID: 11726640
    [Abstract] [Full Text] [Related]

  • 13. Low plasma levels of matrix metalloproteinase 9 permit increased tumor angiogenesis.
    Pozzi A, LeVine WF, Gardner HA.
    Oncogene; 2002 Jan 10; 21(2):272-81. PubMed ID: 11803470
    [Abstract] [Full Text] [Related]

  • 14. Endothelial progenitor cells as putative targets for angiostatin.
    Ito H, Rovira II, Bloom ML, Takeda K, Ferrans VJ, Quyyumi AA, Finkel T.
    Cancer Res; 1999 Dec 01; 59(23):5875-7. PubMed ID: 10606226
    [Abstract] [Full Text] [Related]

  • 15. Angiostatin.
    Cao Y, Xue L.
    Semin Thromb Hemost; 2004 Feb 01; 30(1):83-93. PubMed ID: 15034800
    [Abstract] [Full Text] [Related]

  • 16. Angiostatin enhances B7.1-mediated cancer immunotherapy independently of effects on vascular endothelial growth factor expression.
    Sun X, Kanwar JR, Leung E, Lehnert K, Wang D, Krissansen GW.
    Cancer Gene Ther; 2001 Oct 01; 8(10):719-27. PubMed ID: 11687895
    [Abstract] [Full Text] [Related]

  • 17. The mechanism of action of angiostatin: can you teach an old dog new tricks?
    Moser TL, Stack MS, Wahl ML, Pizzo SV.
    Thromb Haemost; 2002 Mar 01; 87(3):394-401. PubMed ID: 11916069
    [Abstract] [Full Text] [Related]

  • 18. Long-term expression of angiostatin suppresses metastatic liver cancer in mice.
    Xu R, Sun X, Tse LY, Li H, Chan PC, Xu S, Xiao W, Kung HF, Krissansen GW, Fan ST.
    Hepatology; 2003 Jun 01; 37(6):1451-60. PubMed ID: 12774025
    [Abstract] [Full Text] [Related]

  • 19. Angiostatin potentiates cyclophosphamide treatment of metastatic disease.
    Mauceri HJ, Seetharam S, Beckett MA, Schumm LP, Koons A, Gupta VK, Park JO, Manan A, Lee JY, Montag AG, Kufe DW, Weichselbaum RR.
    Cancer Chemother Pharmacol; 2002 Nov 01; 50(5):412-8. PubMed ID: 12439600
    [Abstract] [Full Text] [Related]

  • 20. Continuous administration of angiostatin inhibits accelerated growth of colorectal liver metastases after partial hepatectomy.
    Drixler TA, Borel Rinkes IH, Ritchie ED, van Vroonhoven TJ, Gebbink MF, Voest EE.
    Cancer Res; 2000 Mar 15; 60(6):1761-5. PubMed ID: 10749151
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.